-
Ligand to Participate in September Investor Conferences
19 Aug 2025 20:00 GMT
… 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today … C. Wainwright representative. About Ligand Pharmaceuticals
Ligand is a biopharmaceutical company … ’s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, …
-
Ligand Announces Closing of Convertible Senior Notes Offering
14 Aug 2025 20:00 GMT
… results, performance or achievements. About Ligand Pharmaceuticals
Ligand is a biopharmaceutical company enabling … world’s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, Gilead Sciences …
-
Ligand Announces Pricing of $400 Million Convertible Senior Notes Offering
12 Aug 2025 03:46 GMT
… results, performance or achievements. About Ligand Pharmaceuticals
Ligand is a biopharmaceutical company enabling … world’s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, Gilead Sciences …
-
Ligand Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030
11 Aug 2025 11:00 GMT
… results, performance or achievements. About Ligand Pharmaceuticals
Ligand is a biopharmaceutical company enabling … world’s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, Gilead Sciences …
-
Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance
07 Aug 2025 11:00 GMT
… is available at www.ligand.com. About Ligand Pharmaceuticals Ligand is a biopharmaceutical company … world’s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, Gilead Sciences …
-
Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed
31 Jul 2025 20:01 GMT
… in cumulative revenue share. About Ligand Pharmaceuticals
Ligand is a biopharmaceutical company enabling … world’s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, Gilead Sciences …
-
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q2 2025 Earnings Call Transcript
02 Aug 2025 12:35 GMT
… August 1, 2025
Regeneron Pharmaceuticals, Inc. beats earnings expectations … Welcome to the Regeneron Pharmaceuticals Second Quarter 2025 Earnings … over. That was Lilly, Pfizer, and Regeneron, and it … on the competitive OX40 ligand data shared thus far …
-
Ligand to Report Second Quarter 2025 Financial Results on August 7, 2025
24 Jul 2025 11:00 GMT
… 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today … available here.
About Ligand Pharmaceuticals
Ligand is a biopharmaceutical company enabling … ’s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, …
-
Ligand Partner Pelthos Therapeutics Launches ZELSUVMI™
10 Jul 2025 12:00 GMT
… , 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today … www.zelsuvmi.com. About Ligand Pharmaceuticals
Ligand is a biopharmaceutical company enabling … world’s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, …
-
Cornus officinalis Protects Against Steroid-Induced Osteonecrosis of the Femoral Head Through Inhibiting Inflammatory Responses and Apoptosis via Network Pharmacology and Experimental Validation
08 Jul 2025 20:35 GMT
… possible by verifying predicted ligand-receptor interactions from network … weight of methylprednisolone (MPS; Pfizer, USA) were administered at … Benson N. Systems pharmacology: bridging systems biology and pharmacokinetics-pharmacodynamics (PKPD) in drug …